Center of Excellence - Pharma 4.0 by Dr. Jayant Joshi

Quantum Leap: Transforming Pharma Supply Chains by 2028

Quantum Leap: Transforming Pharma Supply Chains by 2028In this forward-looking episode, we explore how quantum computing is set to redefine pharmaceutical supply chains between 2026 and 2028—marking a pivotal shift from experimental innovation to real-world operational advantage.
As the pharma industry grapples with increasing complexity—globalized distribution networks, temperature-sensitive biologics, and unpredictable disruptions—traditional systems are reaching their limits. This episode dives into how hybrid quantum-classical computing is emerging as a powerful solution to tackle NP-hard logistics challenges that were previously unsolvable at scale.
We unpack six critical domains where quantum technologies will create transformative impact:
Route optimization for multi-modal, cold-chain distribution
Biologics integrity through advanced risk-based logistics modeling
Demand forecasting powered by quantum machine learning
Real-time supply chain resilience and disruption recovery
Anti-counterfeiting through quantum-secured serialization
Manufacturing scheduling and resource optimization
Beyond efficiency gains, we also address a crucial and urgent shift: post-quantum cryptography. As quantum capabilities evolve, current encryption methods will become vulnerable—making it essential for pharma organizations to future-proof their data security today.
The episode also highlights the rise of cloud-based quantum platforms, enabling scalable access without heavy infrastructure investments, and outlines a practical roadmap for pharma leaders to begin their quantum journey—from building data readiness to developing quantum literacy.
Whether you're a supply chain leader, digital transformation strategist, or Pharma 4.0 innovator, this episode offers actionable insights into how quantum computing will reshape the economics, resilience, and intelligence of pharma distribution by 2028.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #QuantumComputing #SupplyChainTransformation #DigitalPharma #PharmaInnovation #ColdChain #QuantumAI #FutureOfPharma #HealthcareLogistics #PostQuantumSecurity #PharmaSupplyChain #EmergingTech #DigitalTransformation #LifeSciences #QuantumLeap
 

Pharma’s Financial Edge: The Supply Chain Weapon

Pharma’s Financial Edge: The Supply Chain Weapon
In this episode, we explore how leading pharmaceutical companies are transforming supply chain finance (SCF) into a powerful strategic advantage. What was once a back-office treasury function is now emerging as a critical lever to unlock liquidity, strengthen supplier ecosystems, and fund innovation—without increasing debt.
The pharma industry is under intense pressure: a looming patent cliff, rising R&D costs, fragile global supply chains, and growing ESG expectations. At the same time, billions in working capital remain trapped due to long cash conversion cycles. This episode breaks down how embedded finance solutions are helping companies turn this challenge into an opportunity.
We dive into how SCF enables pharma leaders to free up capital for R&D and M&A, extend payment terms without harming supplier health, and build resilient, loyal supplier networks. You’ll also learn how advanced technologies like AI, blockchain, and ERP-integrated platforms are reshaping SCF into a real-time, data-driven capability within Pharma 4.0.
From deep-tier financing to sustainability-linked programs, we unpack real-world applications and strategic frameworks that are redefining financial agility in pharma. This is not just about finance—it’s about competitive positioning, risk mitigation, and future-proofing the pharmaceutical value chain.
If you're a pharma leader, supply chain strategist, or finance professional, this episode will give you a fresh perspective on how financial innovation can become a true operational weapon.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #SupplyChainFinance #PharmaInnovation #WorkingCapital #EmbeddedFinance #PharmaSupplyChain #DigitalTransformation #ESG #FinTech #PharmaLeadership #CashFlowOptimization #BlockchainInPharma #AIinPharma #StrategicFinance #PharmaGrowth
 

From Forecasting to Decision Intelligence: The Next Evolution of AI-Powered Pharma Supply Chains

From Forecasting to Decision Intelligence: The Next Evolution of AI-Powered Pharma Supply Chains
In this episode, we explore a pivotal transformation redefining pharmaceutical supply chains—moving beyond traditional AI-powered forecasting toward Decision Intelligence (DI).
For years, forecasting has helped pharma organizations anticipate demand, reduce stockouts, and improve planning accuracy. But in an industry defined by complexity, regulatory constraints, perishability, and patient-critical outcomes, prediction alone is no longer enough.
This episode dives deep into how Decision Intelligence is emerging as the next frontier—bridging the long-standing gap between insight and action. Instead of simply predicting what might happen, DI systems enable organizations to determine—and execute—what should be done in real time, at scale.
We unpack the limitations of forecasting in multi-echelon pharma networks and explain why dashboards and alerts often fail to translate into timely decisions. From cold-chain failures costing billions annually to life-saving therapies delayed due to operational inefficiencies, the stakes have never been higher.
Listeners will gain a clear understanding of:
The evolution from predictive to prescriptive and now autonomous decision-making
How agentic AI enables real-time, self-governing supply chain actions
The role of digital twins in simulating disruptions and optimizing outcomes before execution
How AI-powered control towers transform visibility into action
The architecture behind closed-loop, self-learning supply chains
We also examine real-world impact—ranging from significant reductions in stockouts and operational costs to faster disruption recovery and improved patient outcomes.
Finally, the episode outlines a practical roadmap for pharma leaders looking to transition from forecasting to Decision Intelligence—covering data foundations, pilot strategies, governance frameworks, and regulatory considerations.
As Pharma 4.0 continues to evolve, the competitive advantage will no longer lie in what organizations can predict—but in how effectively they can act.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #DecisionIntelligence #SupplyChainAI #PharmaSupplyChain #DigitalTransformation #AgenticAI #DigitalTwin #AIinHealthcare #SmartSupplyChain #ControlTower #PharmaInnovation #AITransformation #HealthcareLogistics #FutureOfPharma #DataDrivenDecisions
 

The Agentic Evolution of Pharmaceutical Finance and Audit Automation

The Agentic Evolution of Pharmaceutical Finance and Audit Automation
In this episode of Center of Excellence - Pharma 4.0, we explore the transformative journey of pharmaceutical finance and audit functions—from manual, retrospective processes to intelligent, autonomous compliance ecosystems.
“The Agentic Evolution of Pharmaceutical Finance and Audit Automation” unpacks how the Office of the CFO is evolving into a strategic orchestrator of enterprise-wide compliance. Traditionally burdened with complex regulatory frameworks such as GxP and 21 CFR Part 11, finance teams relied heavily on labor-intensive audits and reactive remediation strategies.
Today, that paradigm is being redefined.
We begin by examining the foundational phase of Generative AI, where large language models accelerated regulatory documentation, audit narratives, and CAPA reporting—delivering measurable efficiency gains and improving audit quality. Early implementations demonstrated remarkable outcomes, including significant reductions in manual effort and enhanced accuracy in compliance reporting.
The conversation then shifts to the next frontier: Agentic AI.
Unlike traditional AI systems, agentic architectures introduce continuous, real-time monitoring across financial and clinical systems. These intelligent agents autonomously detect anomalies, perform cross-system validation, initiate stakeholder interactions, and generate regulator-ready reports—transforming compliance from a periodic exercise into a 24/7 surveillance model.
We also dive into high-impact use cases, including:
Autonomous financial anomaly detection and investigation
Near-touchless pharmacovigilance and safety case processing
Accelerated clinical trial financial infrastructure setup
AI-driven billing and coding optimization
Beyond productivity gains, the episode critically addresses governance, data privacy, and regulatory risks. As AI becomes deeply embedded in compliance workflows, CFOs must adopt “governance-first” architectures, ensuring transparency, auditability, and adherence to global data protection mandates.
With real-world insights, measurable ROI outcomes, and a phased implementation roadmap, this episode provides a strategic lens into how pharmaceutical organizations can transition toward intelligent, autonomous compliance systems.
The future of pharma finance is not just automated—it is agentic, predictive, and continuously compliant.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #PharmaceuticalIndustry #AIinHealthcare #AgenticAI #GenerativeAI #DigitalTransformation #CFOLeadership #AuditAutomation #RegulatoryCompliance #GxP #Pharmacovigilance #HealthTech #AIInnovation #FutureOfFinance #EnterpriseAI
 

The Evolution of Pharmaceutical Sales Forecasting and Agentic AI Intelligence

The Evolution of Pharmaceutical Sales Forecasting and Agentic AI IntelligenceIn this episode, we explore the transformative journey of pharmaceutical sales forecasting—from traditional spreadsheet-driven models to the cutting-edge era of Agentic AI intelligence.
Pharmaceutical forecasting has always been uniquely complex, shaped by multi-channel access systems, dynamic payer landscapes, evolving healthcare professional (HCP) adoption patterns, and critical lifecycle events like loss of exclusivity. Historically, commercial finance teams struggled to synthesize fragmented datasets into accurate, actionable insights, often relying on static and reactive forecasting approaches.
We begin by examining the first wave of AI adoption—Generative AI—which revolutionized reporting efficiency, automated executive presentations, and enabled natural-language interaction with data. While impactful, this phase remained largely descriptive and retrospective.
The conversation then advances into the current frontier: Agentic AI. Unlike its predecessor, Agentic AI functions as an autonomous forecasting orchestrator—continuously ingesting vast datasets, running probabilistic simulations, and dynamically updating forecasts in real time. This shift enables:
Hyper-granular, sub-national forecasting precision
Real-time detection of market events and competitive threats
Continuous model retraining and scenario simulation
Data-driven commercial decision-making at unprecedented speed
We also unpack how Agentic AI is compressing drug launch timelines from 6–18 months to as little as 4–5 months—unlocking massive financial value and accelerating time-to-market in a highly competitive industry.
Finally, the episode addresses governance, implementation strategies, and the importance of maintaining a human-in-the-loop approach—ensuring that AI augments, rather than replaces, strategic decision-making.
This episode is essential listening for pharmaceutical leaders, CFOs, commercial strategists, and anyone navigating the future of Pharma 4.0—where predictive intelligence is no longer optional, but a strategic imperative.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #PharmaceuticalIndustry #AIinHealthcare #AgenticAI #GenerativeAI #SalesForecasting #CommercialExcellence #PharmaInnovation #HealthcareAnalytics #DigitalTransformation #CFOInsights #LifeSciences #DataDriven #FutureOfPharma #AITransformation
 

AI-Driven Drug Pricing Strategy and Gross-to-Net Optimization

AI-Driven Drug Pricing Strategy and Gross-to-Net Optimization
In this episode of Center of Excellence – Pharma 4.0, we explore how artificial intelligence is revolutionizing one of the most complex and financially critical areas in the pharmaceutical industry: drug pricing strategy and Gross-to-Net (GTN) optimization.
The discussion begins by unpacking the intricate structure of the GTN “bubble”—the widening gap between a drug’s list price and the actual net revenue realized by manufacturers. From commercial payer rebates and government mandates to distribution fees and patient support programs, we break down how value leakage occurs and why traditional spreadsheet-based approaches are no longer sufficient.
We then trace the evolution of AI in this space. The first wave, driven by Generative AI, focused on improving operational efficiency—automating market access dossiers, summarizing payer policies, and accelerating rebate documentation. While impactful, these tools remained limited to text generation and lacked the ability to simulate real financial outcomes.
The episode dives deeper into the transformative shift toward Agentic AI, where autonomous systems actively model GTN dynamics in real time. These advanced platforms ingest live data—from payer coverage and pricing benchmarks to channel mix—and run complex simulations within minutes. This enables finance leaders to proactively evaluate pricing decisions, mitigate risks, and optimize net revenue before contracts are finalized.
We also examine how AI is helping pharma organizations navigate mounting external pressures, including regulatory changes such as the Inflation Reduction Act, global pricing constraints, and the rise of biosimilar competition. By continuously monitoring and simulating these variables, AI empowers companies to protect margins and maintain strategic agility in a rapidly evolving market.
Finally, the episode highlights measurable outcomes and ROI, showcasing how even small improvements in GTN yield can translate into significant financial gains at scale. We conclude with a practical roadmap for implementation—guiding organizations from data consolidation and generative enablement to fully integrated, continuously governed AI-driven pricing ecosystems.
This episode is essential listening for pharma executives, CFOs, and digital transformation leaders seeking to move beyond reactive pricing strategies and embrace AI-powered revenue intelligence as a competitive advantage.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#PharmaFinance #RevenueOptimization #DigitalTransformation #LifeSciences #MarketAccess #AITransformation #PharmaStrategy #CFOInsights #HealthcareAI
 

Agentic AI and Cost Optimization in Pharmaceutical Indirect Spend

Agentic AI and Cost Optimization in Pharmaceutical Indirect SpendIn this insightful episode, we explore how the pharmaceutical industry is transforming one of its most complex and overlooked financial areas—indirect spend—through the power of Agentic AI. Traditionally plagued by fragmented data, limited visibility, and inefficiencies, indirect spend has long remained a blind spot for CFOs and procurement leaders.
We begin by unpacking the evolution from Generative AI to Agentic AI. While Generative AI laid the foundation by structuring unorganized procurement data and enabling visibility, Agentic AI takes a leap forward—acting autonomously to monitor, analyze, and optimize financial operations in real time. These intelligent agents continuously scan thousands of transactions, detect anomalies, prevent duplicate or unauthorized payments, and enforce contract compliance without human intervention.
The episode dives deep into how pharmaceutical organizations are leveraging these capabilities across complex ecosystems—ranging from clinical research outsourcing and logistics to facility management and professional services. We highlight how AI enables granular, line-item level intelligence, uncovering inefficiencies that can reduce costs by up to 10% across multi-billion-dollar spend bases.
A key focus is on real-time anomaly detection—one of the fastest-scaling AI use cases in finance today. By shifting from reactive auditing to proactive prevention, organizations can stop financial leakage before it occurs, drastically reducing audit cycles and improving operational efficiency.
Beyond cost savings, we also examine how Agentic AI is driving strategic outcomes—supporting ESG goals, promoting supplier diversity, and optimizing sustainable procurement practices. From recommending eco-friendly vendors to enabling circular logistics models, AI is aligning financial decisions with broader corporate responsibility.
Finally, we discuss measurable business impact, including significant cost reductions, faster ROI, and the transformation of the CFO’s role into a strategic architect of enterprise efficiency. This episode provides a practical roadmap for implementing Agentic AI—from data normalization to autonomous spend orchestration—offering valuable insights for finance, procurement, and digital transformation leaders.
This is not just about cost optimization—it’s about redefining how pharmaceutical enterprises operate in the era of intelligent automation.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #AgenticAI #ArtificialIntelligence #PharmaIndustry #DigitalTransformation #CostOptimization #Procurement #IndirectSpend #CFO #FinanceTransformation #AIinPharma #SmartProcurement #ESG #Automation #FutureOfWork
 

The CFO as P&L Architect: Revolutionizing Pharma Supply Chain Finance

The CFO as P&L Architect: Revolutionizing Pharma Supply Chain Finance
In today’s rapidly evolving pharmaceutical landscape, the role of the CFO is undergoing a profound transformation—from a traditional financial steward to a strategic architect of enterprise profitability. This episode dives deep into how supply chain finance has emerged as the most powerful lever for value creation in Pharma 4.0.
We explore how the convergence of advanced technologies—particularly the shift from Generative AI to Agentic AI—is redefining how pharmaceutical companies manage complexity, risk, and capital. What was once a fragmented, reactive supply chain is now becoming a real-time, AI-driven engine for continuous P&L optimization.
Listeners will gain insights into:
The inherent volatility and structural complexity of pharmaceutical supply chains
The financial burden of “just-in-case” inventory and trapped working capital
How Generative AI enhanced visibility through automated financial narratives
The rise of Agentic AI and digital control towers enabling autonomous decision-making
The three-layer architecture powering intelligent supply chain operations—data, orchestration, and execution
The critical partnership between CFOs and Chief Supply Chain Officers (CSCOs) in driving aligned outcomes
Real-world financial impact, including significant reductions in inventory costs and supply chain expenses
A practical roadmap for CFOs to transition from insight-driven to autonomous, AI-enabled execution
This episode ultimately reframes the supply chain as a dynamic financial instrument—one that directly influences EBITDA, working capital efficiency, and long-term enterprise value. It highlights why the modern CFO must lead this transformation and embrace AI not just as a tool, but as a strategic capability.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #SupplyChainFinance #CFOLeadership #DigitalTransformation #AgenticAI #GenerativeAI #PharmaInnovation #WorkingCapital #EBITDA #AIinPharma #FinanceTransformation #SmartSupplyChain #ControlTower #FutureOfFinance #PharmaLeadership
 

Predictive Cash Harvesting: The Agentic AI Revolution in Pharma O2C

Predictive Cash Harvesting: The Agentic AI Revolution in Pharma O2C
In this episode, we explore a transformational shift redefining the financial backbone of the pharmaceutical industry—the evolution of the Order-to-Cash (O2C) process from reactive collections to predictive, AI-driven revenue orchestration.
Pharma O2C has long been burdened by complexity: fragmented distribution networks, intricate Gross-to-Net (GTN) calculations, payer disputes, and delayed cash realization. Traditional approaches relied heavily on manual interventions, spreadsheet-based forecasting, and reactive collections strategies—leading to high Days Sales Outstanding (DSO) and significant value leakage.
We begin by unpacking the limitations of the initial wave of Generative AI, which improved communication, dispute summarization, and reporting efficiency but still required human-driven execution. While it enhanced productivity, it did not fundamentally transform the revenue cycle.
The episode then dives into the emergence of Agentic AI, marking a paradigm shift toward Predictive Cash Harvesting. These intelligent, autonomous systems continuously analyze payment behaviors, detect risks before they materialize, and initiate proactive interventions—without human prompting. From predicting delayed payments to dynamically prioritizing collections strategies, Agentic AI transforms O2C into a real-time, self-optimizing engine.
We also explore how AI is revolutionizing Gross-to-Net optimization through multi-variable simulations, enabling finance leaders to evaluate complex payer scenarios, reduce margin erosion, and eliminate hidden value leakage. Additionally, the episode highlights the role of autonomous claims validation and dispute resolution, drastically reducing billing errors, accelerating settlements, and unlocking trapped working capital.
Finally, we outline a strategic roadmap for implementation—from data harmonization and predictive analytics deployment to fully autonomous workflows and GTN integration—empowering CFOs to reposition O2C from a back-office function to a strategic growth lever.
This episode is a must-listen for finance leaders, digital transformation experts, and pharma executives seeking to harness AI for smarter cash flow management, operational excellence, and enterprise value creation.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma4_0 #AgenticAI #PredictiveCashHarvesting #OrderToCash #RevenueCycle #PharmaInnovation #AIinFinance #DigitalTransformation #WorkingCapital #GrossToNet #HealthcareAI #FinanceTransformation #CFOInsights #PharmaTech #IntelligentAutomation
 

Agentic AI and Autonomous Invoice Intelligence in Pharmaceutical P2P

Agentic AI and Autonomous Invoice Intelligence in Pharmaceutical P2PIn this episode of Center of Excellence - Pharma 4.0, we explore how Agentic AI is redefining the Procure-to-Pay (P2P) landscape in the pharmaceutical industry—transforming it from a fragmented, manual process into an intelligent, autonomous value driver.
Pharmaceutical P2P has long been burdened by supplier complexity, regulatory rigor, data silos, and the inefficiencies of traditional three-way matching. These challenges often result in delayed payments, compliance risks, and significant contract value leakage—where negotiated savings fail to materialize on invoices.
We begin by unpacking the evolution from Generative AI to Agentic AI. While early AI systems focused on extracting invoice data and flagging discrepancies, today’s agentic systems go much further. They autonomously manage end-to-end workflows—validating invoices, reconciling purchase orders in real time, resolving discrepancies, and even interacting with suppliers without human intervention.
A key highlight of the episode is the concept of Autonomous Invoice Intelligence—where AI agents continuously monitor transactions, enforce contract compliance, and ensure audit-ready execution. These systems can reduce P2P cycle times by up to 80%, while simultaneously improving accuracy and regulatory adherence.
We also dive into one of the most impactful outcomes: eliminating contract leakage. By aligning invoices with complex contractual terms—such as tiered pricing, rebates, and SLAs—Agentic AI can recover up to 4% of total spend. For large pharmaceutical organizations, this translates into tens of millions in recurring margin improvements.
Beyond finance efficiency, the episode explores how AI enables proactive vendor performance management—preventing duplicate payments, tracking service-level agreements in real time, and identifying supplier risks before they disrupt operations.
Finally, we outline a practical roadmap for adoption, emphasizing the importance of data governance, phased implementation, and human-in-the-loop controls to ensure transparency and compliance in highly regulated environments.
This episode is a must-listen for CFOs, procurement leaders, and digital transformation teams looking to turn P2P from a back-office function into a strategic engine for profitability and resilience.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#AgenticAI #Pharma40 #ProcureToPay #P2PTransformation #AutonomousFinance #InvoiceAutomation #AIInPharma #DigitalTransformation #FinanceInnovation #IntelligentAutomation #SupplyChainAI #ERP #CFOInsights #DataDriven #FutureOfWork